MID-VOLUME · SEX-BALANCED
valbenazine Side Effects
valbenazine (also sold as Ingrezza) sits MID-VOLUME #214 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 67% of sex-coded reports are female (10,449 F / 5,128 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 24,340
- FAERS reports
FDA Adverse Event Reporting System extract for valbenazine. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.
valbenazine reporting skew - 67% of sex-coded reports are female (10,449 F / 5,128 M). Volume band MID-VOLUME #214 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for valbenazine (Ingrezza) (24,340 reports). Signature SEX-BALANCED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2017–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
SOMNOLENCE leads 2,412 of 24,340 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (4,105 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,271 reports, 5.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 911 |
| COMPLETED SUICIDE | 38 |
| HOSPITALISATION | 36 |
| MYOCARDIAL INFARCTION | 32 |
| PNEUMONIA | 31 |
| FALL | 28 |
| COVID-19 | 27 |
| CARDIAC ARREST | 21 |
| PNEUMONIA ASPIRATION | 20 |
| URINARY TRACT INFECTION | 18 |
| NEOPLASM MALIGNANT | 17 |
| SEPSIS | 17 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 15 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 12 |
| DYSPHAGIA | 11 |
| CARDIAC FAILURE CONGESTIVE | 10 |
| DYSPNOEA | 10 |
| CEREBROVASCULAR ACCIDENT | 9 |
| CHOKING | 9 |
Reactions in Hospitalization Reports
Hospitalization mid-share (3,386, 13.9%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| HOSPITALISATION | 650 |
| FALL | 411 |
| PNEUMONIA | 119 |
| URINARY TRACT INFECTION | 113 |
| TARDIVE DYSKINESIA | 111 |
| TREMOR | 109 |
| DEPRESSION | 99 |
| DEATH | 93 |
| DIZZINESS | 88 |
| SOMNOLENCE | 84 |
| SUICIDAL IDEATION | 80 |
| ANXIETY | 78 |
| COVID-19 | 72 |
| ASTHENIA | 71 |
| GAIT DISTURBANCE | 71 |
| PARKINSONISM | 63 |
| DEHYDRATION | 59 |
| DYSPNOEA | 59 |
How to read valbenazine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 24,340 voluntary reports linked to valbenazine (Ingrezza), 2017-2025. Death is listed on 1,271 (5.2%). Hospitalization appears on 3,386 (13.9%). Top co-reported indication: Tardive Dyskinesia.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 67% of sex-coded reports are female (10,449 F / 5,128 M).
Read with valbenazine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 24,367 FAERS cases (Δ 27 heavier vs valbenazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,428 FAERS cases (Δ 88 heavier vs valbenazine); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,014 FAERS cases (Δ 326 lighter vs valbenazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,667 FAERS cases (Δ 327 heavier vs valbenazine); DEATH-MARKED · HOSP-LIGHT · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 56.9 pp vs valbenazine's DEATH-HEAVY): CASELOAD · HOSP-MID.
valbenazine stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.